Healthcare Sector Stocks
The Healthcare sector has a total of 1058 stocks, with a combined market cap of $8.51 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.29.
Market Cap
8.51T
Revenue
4.59T
Profits
201.2B
PE Ratio
42.29
Profit Margin
4.38%
Dividend Yield
0.43%
1059 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | 2.13% | 1,358,678 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 576.96B | 0.50% | 2,592,014 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 399.33B | 0.48% | 1,745,653 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 369.83B | -0.05% | 2,292,551 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 300.70B | 2.23% | 4,826,796 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 279.76B | 1.65% | 867,485 | 60.44B |
| 7 | NVS | Novartis AG | 273.10B | 3.39% | 1,114,403 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 194.01B | 1.99% | 7,298,846 | 50.57B |
| 9 | AMGN | Amgen Inc. | 190.10B | 4.29% | 2,267,167 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 174.76B | -2.44% | 666,541 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 156.88B | 4.02% | 3,111,226 | 29.74B |
| 12 | ABT | Abbott Laboratories | 156.66B | 0.86% | 3,933,939 | 45.13B |
| 13 | PFE | Pfizer Inc. | 149.67B | 2.58% | 24,426,144 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 146.04B | 0.08% | 854,919 | 10.58B |
| 15 | DHR | Danaher Corporation | 126.92B | -2.34% | 1,198,228 | 24.78B |
| 16 | CVS | CVS Health Corporation | 126.83B | 1.41% | 5,896,220 | 405.62B |
| 17 | SYK | Stryker Corporation | 117.14B | -1.06% | 732,084 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 116.33B | 2.46% | 3,366,012 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 112.02B | 1.30% | 348,490 | 12.22B |
| 20 | SNY | Sanofi | 105.41B | 1.15% | 2,334,785 | 54.60B |
| 21 | MDT | Medtronic plc | 103.61B | 0.56% | 3,467,271 | 36.36B |
| 22 | GSK | GSK plc | 102.76B | 2.79% | 2,662,995 | 43.29B |
| 23 | MCK | McKesson Corporation | 95.84B | 0.86% | 342,293 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 86.90B | -1.09% | 993,715 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 83.86B | 1.25% | 650,594 | 76.39B |
| 26 | CI | The Cigna Group | 78.12B | -0.16% | 331,755 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 70.57B | -1.78% | 9,881,413 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.67B | 2.39% | 340,137 | 14.92B |
| 29 | COR | Cencora, Inc. | 55.27B | 1.00% | 344,158 | 328.68B |
| 30 | ARGX | argenx SE | 54.82B | 3.54% | 168,430 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 52.16B | 2.97% | 1,141,804 | 250.74B |
| 32 | EW | Edwards Lifesciences Corporation | 49.75B | 0.49% | 1,707,646 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 49.55B | 0.96% | 980,552 | 28.34B |
| 34 | MDLN | Medline Inc. | 47.96B | -0.08% | 2,407,728 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.19B | 0.59% | 305,151 | 4.45B |
| 36 | HUM | Humana Inc. | 44.00B | 0.56% | 496,971 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 40.52B | -0.51% | 633,813 | 22.23B |
| 38 | HLN | Haleon plc | 40.13B | -0.33% | 9,711,569 | 14.85B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 40.02B | 2.35% | 1,938,888 | 17.35B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.99B | 0.28% | 368,266 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 36.25B | -2.50% | 530,883 | 7.23B |
| 42 | WAT | Waters Corporation | 34.80B | -2.41% | 253,313 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 33.98B | -0.28% | 3,739,901 | 9.53B |
| 44 | ALC | Alcon Inc. | 32.80B | 0.12% | 621,098 | 10.63B |
| 45 | RVMD | Revolution Medicines, Inc. | 31.85B | 3.90% | 1,088,736 | - |
| 46 | RPRX | Royalty Pharma plc | 31.71B | 1.01% | 1,139,030 | 2.44B |
| 47 | CNC | Centene Corporation | 31.34B | -2.88% | 1,868,241 | 178.33B |
| 48 | NTRA | Natera, Inc. | 31.03B | 0.07% | 303,200 | 2.50B |
| 49 | IQV | IQVIA Holdings Inc. | 30.06B | -1.13% | 643,515 | 16.63B |
| 50 | BIIB | Biogen Inc. | 29.44B | 2.66% | 294,858 | 9.94B |
| 51 | GEHC | GE HealthCare Technologies Inc. | 29.24B | 0.83% | 1,032,157 | 20.98B |
| 52 | ONC | BeOne Medicines AG | 29.04B | -0.90% | 273,168 | 5.70B |
| 53 | DXCM | DexCom, Inc. | 28.98B | 0.44% | 1,743,528 | 4.82B |
| 54 | RMD | ResMed Inc. | 27.73B | -0.81% | 347,606 | 5.54B |
| 55 | VEEV | Veeva Systems Inc. | 26.51B | -0.36% | 663,578 | 3.32B |
| 56 | PHG | Koninklijke Philips N.V. | 24.71B | 0.35% | 516,837 | 20.34B |
| 57 | ILMN | Illumina, Inc. | 24.57B | -0.05% | 562,686 | 4.39B |
| 58 | UTHR | United Therapeutics Corporation | 23.38B | 1.21% | 164,848 | 3.17B |
| 59 | WST | West Pharmaceutical Services, Inc. | 23.15B | -0.99% | 172,408 | 3.22B |
| 60 | MTD | Mettler-Toledo International Inc. | 22.71B | -0.80% | 27,928 | 4.09B |
| 61 | DGX | Quest Diagnostics Incorporated | 22.54B | -0.06% | 466,795 | 11.28B |
| 62 | BNTX | BioNTech SE | 22.39B | 2.77% | 1,716,184 | 3.23B |
| 63 | INCY | Incyte Corporation | 21.82B | 3.64% | 984,845 | 5.36B |
| 64 | LH | Labcorp Holdings Inc. | 21.79B | -1.06% | 156,035 | 14.14B |
| 65 | ROIV | Roivant Sciences Ltd. | 21.19B | 3.68% | 2,513,584 | 8.26M |
| 66 | INSM | Insmed Incorporated | 21.02B | 5.55% | 2,807,641 | 819.56M |
| 67 | STE | STERIS plc | 20.19B | -0.58% | 229,161 | 5.94B |
| 68 | MRNA | Moderna, Inc. | 19.19B | 5.18% | 3,062,990 | 2.23B |
| 69 | VTRS | Viatris Inc. | 18.59B | 1.20% | 4,108,207 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.41B | 0.44% | 824,288 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 16.94B | -0.67% | 759,812 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.34B | 1.04% | 280,651 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.26B | 2.29% | 588,682 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 14.81B | 4.36% | 493,795 | 21.46B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.76B | 2.45% | 338,258 | 4.44B |
| 76 | SOLV | Solventum Corporation | 13.61B | -2.93% | 431,181 | 8.26B |
| 77 | MEDP | Medpace Holdings, Inc. | 13.55B | 1.89% | 87,421 | 2.68B |
| 78 | ASND | Ascendis Pharma A/S | 13.47B | 3.37% | 141,467 | 998.25M |
| 79 | EXEL | Exelixis, Inc. | 13.46B | 1.83% | 660,476 | 2.38B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 13.40B | 1.48% | 755,775 | 579.96M |
| 81 | SNN | Smith & Nephew plc | 13.18B | -0.97% | 625,248 | 6.16B |
| 82 | AXSM | Axsome Therapeutics, Inc. | 13.17B | 3.92% | 302,070 | 708.24M |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.13B | 4.03% | 1,143,974 | 13.65B |
| 84 | COO | The Cooper Companies, Inc. | 13.09B | -0.83% | 1,400,990 | 4.23B |
| 85 | DVA | DaVita Inc. | 13.00B | 2.01% | 317,630 | 13.84B |
| 86 | PEN | Penumbra, Inc. | 12.54B | -0.19% | 147,673 | 1.45B |
| 87 | ALGN | Align Technology, Inc. | 12.40B | 1.56% | 500,380 | 4.10B |
| 88 | IONS | Ionis Pharmaceuticals, Inc. | 12.22B | 0.88% | 693,900 | 1.06B |
| 89 | FMS | Fresenius Medical Care AG | 12.05B | 0.27% | 256,185 | 22.32B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.71B | 2.54% | 1,598,437 | 4.89B |
| 91 | RVTY | Revvity, Inc. | 11.25B | -0.48% | 401,770 | 2.90B |
| 92 | ICLR | ICON Public Limited Company | 11.17B | 0.85% | 240,212 | 8.25B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.14B | 0.04% | 509,132 | 3.58B |
| 94 | GMED | Globus Medical, Inc. | 10.97B | -0.01% | 356,440 | 3.10B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.92B | 0.49% | 136,916 | 1.13B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.81B | -0.43% | 696,184 | 3.24B |
| 97 | BAX | Baxter International Inc. | 10.52B | 0.27% | 3,400,172 | 11.32B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.49B | 5.26% | 516,052 | 622.01M |
| 99 | SMMT | Summit Therapeutics Inc. | 10.39B | 2.61% | 4,930,312 | - |
| 100 | PODD | Insulet Corporation | 10.33B | -1.00% | 492,673 | 2.90B |
| 101 | EHC | Encompass Health Corporation | 10.32B | 0.63% | 185,092 | 6.07B |
| 102 | MOH | Molina Healthcare, Inc. | 9.99B | -3.05% | 515,612 | 43.10B |
| 103 | NUVL | Nuvalent, Inc. | 9.75B | 0.07% | 4,866,256 | - |
| 104 | CYTK | Cytokinetics, Incorporated | 9.52B | 4.55% | 678,119 | 105.82M |
| 105 | KRYS | Krystal Biotech, Inc. | 9.48B | 2.91% | 253,829 | 417.30M |
| 106 | MASI | Masimo Corporation | 9.42B | - | - | 1.56B |
| 107 | RGC | Regencell Bioscience Holdings Limited | 9.41B | -7.09% | 57,929 | - |
| 108 | HSIC | Henry Schein, Inc. | 9.11B | 1.40% | 630,703 | 13.38B |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.90B | -0.86% | 144,201 | 4.03B |
| 110 | UHS | Universal Health Services, Inc. | 8.86B | 1.04% | 254,236 | 17.76B |
| 111 | CORT | Corcept Therapeutics Incorporated | 8.80B | 4.97% | 488,946 | 769.10M |
| 112 | ENSG | The Ensign Group, Inc. | 8.73B | -0.69% | 311,926 | 5.27B |
| 113 | TEM | Tempus AI, Inc. | 8.68B | -2.32% | 3,581,068 | 1.36B |
| 114 | OSCR | Oscar Health, Inc. | 8.66B | 3.27% | 3,167,157 | 13.30B |
| 115 | HALO | Halozyme Therapeutics, Inc. | 8.38B | 0.18% | 435,641 | 1.51B |
| 116 | TECH | Bio-Techne Corporation | 8.28B | 0.74% | 753,241 | 1.21B |
| 117 | BRKR | Bruker Corporation | 8.25B | -1.29% | 909,511 | 3.46B |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.79B | 0.05% | 135,177 | 2.59B |
| 119 | ABVX | ABIVAX Société Anonyme | 7.74B | 1.10% | 775,327 | 5.67M |
| 120 | QGEN | Qiagen N.V. | 7.69B | 0.41% | 1,458,451 | 2.10B |
| 121 | IBRX | ImmunityBio, Inc. | 7.51B | 2.72% | 4,684,738 | 140.98M |
| 122 | ALKS | Alkermes plc | 7.48B | 2.30% | 481,204 | 1.56B |
| 123 | HQY | HealthEquity, Inc. | 7.39B | -1.47% | 195,062 | 1.34B |
| 124 | GKOS | Glaukos Corporation | 7.34B | 2.14% | 211,253 | 551.35M |
| 125 | ATR | AptarGroup, Inc. | 7.33B | 0.18% | 111,020 | 3.87B |
| 126 | RGEN | Repligen Corporation | 7.33B | -0.68% | 218,278 | 763.34M |
| 127 | PTGX | Protagonist Therapeutics, Inc. | 7.03B | 3.40% | 243,040 | 74.06M |
| 128 | PRAX | Praxis Precision Medicines, Inc. | 6.93B | 3.32% | 168,254 | 7.46M |
| 129 | PCVX | Vaxcyte, Inc. | 6.84B | 4.23% | 777,089 | - |
| 130 | SYRE | Spyre Therapeutics, Inc. | 6.82B | 4.57% | 700,017 | - |
| 131 | TGTX | TG Therapeutics, Inc. | 6.80B | 2.85% | 1,259,754 | 700.35M |
| 132 | KYMR | Kymera Therapeutics, Inc. | 6.77B | 5.23% | 301,728 | 51.48M |
| 133 | IMVT | Immunovant, Inc. | 6.71B | 4.87% | 536,904 | - |
| 134 | LNTH | Lantheus Holdings, Inc. | 6.64B | 1.71% | 310,985 | 1.55B |
| 135 | LEGN | Legend Biotech Corporation | 6.57B | 1.52% | 650,454 | 1.14B |
| 136 | AVTR | Avantor, Inc. | 6.53B | -0.83% | 2,187,768 | 6.55B |
| 137 | HIMS | Hims & Hers Health, Inc. | 6.52B | 1.33% | 6,857,169 | 2.37B |
| 138 | APGE | Apogee Therapeutics, Inc. | 6.42B | 3.58% | 278,142 | - |
| 139 | GRFS | Grifols, S.A. | 6.28B | 0.82% | 355,089 | 8.58B |
| 140 | LQDA | Liquidia Corporation | 6.21B | 7.03% | 1,645,690 | 288.07M |
| 141 | PTCT | PTC Therapeutics, Inc. | 6.18B | 1.60% | 821,657 | 827.11M |
| 142 | CNTA | Centessa Pharmaceuticals plc | 6.15B | 0.08% | 343,156 | 15.00M |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.99B | 1.96% | 364,247 | 217.17M |
| 144 | MIRM | Mirum Pharmaceuticals, Inc. | 5.99B | 4.45% | 207,725 | 569.61M |
| 145 | TFX | Teleflex Incorporated | 5.76B | -1.63% | 194,566 | 2.13B |
| 146 | CHE | Chemed Corporation | 5.65B | -1.55% | 121,217 | 2.54B |
| 147 | COGT | Cogent Biosciences, Inc. | 5.56B | 3.66% | 711,585 | - |
| 148 | PACS | PACS Group, Inc. | 5.47B | 0.61% | 212,742 | 5.43B |
| 149 | BLTE | Belite Bio, Inc | 5.44B | 1.30% | 91,494 | - |
| 150 | BLCO | Bausch + Lomb Corporation | 5.41B | -0.66% | 119,097 | 5.21B |
| 151 | SRRK | Scholar Rock Holding Corporation | 5.30B | 0.41% | 421,077 | - |
| 152 | LGND | Ligand Pharmaceuticals Incorporated | 5.09B | 2.33% | 86,205 | 274.48M |
| 153 | HNGE | Hinge Health, Inc. | 5.09B | 5.91% | 1,085,307 | 646.34M |
| 154 | AMRX | Amneal Pharmaceuticals, Inc. | 5.08B | 3.92% | 1,618,426 | 3.05B |
| 155 | CGON | CG Oncology, Inc. | 5.05B | 4.17% | 284,049 | 5.07M |
| 156 | XENE | Xenon Pharmaceuticals Inc. | 5.03B | 1.40% | 1,048,542 | 7.50M |
| 157 | CAI | Caris Life Sciences, Inc. | 5.02B | 3.44% | 1,062,006 | 907.29M |
| 158 | CRSP | CRISPR Therapeutics AG | 4.86B | 1.94% | 615,715 | 4.10M |
| 159 | SHC | Sotera Health Company | 4.65B | 0.31% | 617,502 | 1.19B |
| 160 | RDNT | RadNet, Inc. | 4.62B | 1.08% | 218,270 | 2.14B |
| 161 | BLLN | BillionToOne, Inc. | 4.60B | 0.67% | 329,599 | 354.54M |
| 162 | STVN | Stevanato Group S.p.A. | 4.56B | -3.19% | 155,036 | 1.39B |
| 163 | TVTX | Travere Therapeutics, Inc. | 4.48B | 3.02% | 1,001,722 | 536.20M |
| 164 | TWST | Twist Bioscience Corporation | 4.39B | 4.00% | 908,520 | 409.48M |
| 165 | ALHC | Alignment Healthcare, Inc. | 4.37B | 2.82% | 3,103,374 | 4.26B |
| 166 | LIVN | LivaNova PLC | 4.36B | 1.26% | 198,795 | 1.43B |
| 167 | CELC | Celcuity Inc. | 4.36B | 1.25% | 509,244 | - |
| 168 | ERAS | Erasca, Inc. | 4.26B | 2.47% | 3,294,925 | - |
| 169 | MMED | MiniMed Group, Inc. | 4.25B | 2.99% | 547,654 | 3.10B |
| 170 | ORKA | Oruka Therapeutics, Inc. | 4.17B | 7.95% | 399,295 | - |
| 171 | DNTH | Dianthus Therapeutics, Inc. | 4.15B | -0.58% | 681,457 | 1.34M |
| 172 | TNGX | Tango Therapeutics, Inc. | 4.14B | -0.24% | 3,167,318 | 56.99M |
| 173 | MMSI | Merit Medical Systems, Inc. | 3.97B | -0.69% | 261,677 | 1.54B |
| 174 | MANE | Veradermics, Incorporated | 3.94B | 1.43% | 93,851 | - |
| 175 | NVST | Envista Holdings Corporation | 3.92B | 0.25% | 682,209 | 2.81B |
| 176 | PBLS | Parabilis Medicines, Inc. | 3.92B | 4.91% | 938,101 | - |
| 177 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.90B | 2.76% | 240,012 | 754.05M |
| 178 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.08% | 412,016 | 596.96M |
| 179 | VCYT | Veracyte, Inc. | 3.80B | -1.10% | 367,570 | 541.74M |
| 180 | IRTC | iRhythm Holdings, Inc. | 3.71B | -1.00% | 165,277 | 787.85M |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.68B | 3.92% | 349,413 | - |
| 182 | ACAD | ACADIA Pharmaceuticals Inc. | 3.67B | 0.99% | 401,169 | 1.10B |
| 183 | HAE | Haemonetics Corporation | 3.67B | 2.51% | 961,152 | 1.33B |
| 184 | DOCS | Doximity, Inc. | 3.65B | -1.46% | 1,512,371 | 644.86M |
| 185 | TXG | 10x Genomics, Inc. | 3.63B | -1.75% | 1,001,253 | 638.78M |
| 186 | WAY | Waystar Holding Corp. | 3.57B | -1.06% | 730,032 | 1.16B |
| 187 | OGN | Organon & Co. | 3.54B | 0.64% | 1,926,353 | 6.16B |
| 188 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.51B | -3.03% | 744,010 | 18.07M |
| 189 | NAMS | NewAmsterdam Pharma Company N.V. | 3.50B | 2.08% | 422,215 | 22.57M |
| 190 | CON | Concentra Group Holdings Parent, Inc. | 3.48B | 2.22% | 572,211 | 2.23B |
| 191 | ICUI | ICU Medical, Inc. | 3.48B | -0.42% | 92,801 | 2.16B |
| 192 | DNLI | Denali Therapeutics Inc. | 3.36B | 2.81% | 460,896 | - |
| 193 | OPCH | Option Care Health, Inc. | 3.29B | -1.96% | 1,004,330 | 5.67B |
| 194 | VKTX | Viking Therapeutics, Inc. | 3.27B | 1.55% | 1,243,201 | - |
| 195 | LFST | LifeStance Health Group, Inc. | 3.23B | 6.11% | 3,346,990 | 1.49B |
| 196 | TLX | Telix Pharmaceuticals Limited | 3.21B | -0.64% | 73,401 | 803.79M |
| 197 | WRBY | Warby Parker Inc. | 3.16B | 2.88% | 1,131,522 | 890.57M |
| 198 | BKD | Brookdale Senior Living Inc. | 3.15B | 0.69% | 1,114,535 | 3.00B |
| 199 | ITGR | Integer Holdings Corporation | 3.13B | 0.85% | 124,319 | 1.86B |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.13B | 7.62% | 958,346 | 415.62M |
| 201 | RLAY | Relay Therapeutics, Inc. | 3.10B | 5.41% | 930,289 | 10.68M |
| 202 | NHC | National HealthCare Corporation | 3.05B | 1.80% | 46,662 | 1.53B |
| 203 | GPCR | Structure Therapeutics Inc. | 3.02B | 2.41% | 522,079 | - |
| 204 | ADPT | Adaptive Biotechnologies Corporation | 3.00B | 9.90% | 2,879,404 | 295.41M |
| 205 | DYN | Dyne Therapeutics, Inc. | 2.97B | 1.70% | 514,523 | - |
| 206 | PRVA | Privia Health Group, Inc. | 2.96B | 2.58% | 333,463 | 2.25B |
| 207 | RCUS | Arcus Biosciences, Inc. | 2.94B | 5.72% | 615,778 | 236.00M |
| 208 | BEAM | Beam Therapeutics Inc. | 2.92B | -0.68% | 816,284 | 164.01M |
| 209 | TARS | Tarsus Pharmaceuticals, Inc. | 2.75B | 4.28% | 169,398 | 535.08M |
| 210 | GRDN | Guardian Pharmacy Services, Inc. | 2.70B | 1.52% | 105,042 | 1.46B |
| 211 | ALMS | Alumis Inc. | 2.66B | 4.04% | 740,430 | 8.40M |
| 212 | DFTX | Definium Therapeutics, Inc. | 2.65B | 4.56% | 773,438 | - |
| 213 | SUPN | Supernus Pharmaceuticals, Inc. | 2.64B | 0.91% | 154,259 | 776.83M |
| 214 | HTFL | HeartFlow, Inc. | 2.64B | 3.98% | 627,273 | 191.42M |
| 215 | IRON | Disc Medicine, Inc. | 2.60B | 1.34% | 75,302 | - |
| 216 | TMDX | TransMedics Group, Inc. | 2.58B | - | 418,009 | 635.89M |
| 217 | GRAL | GRAIL, Inc. | 2.57B | 2.07% | 227,812 | 156.12M |
| 218 | KLRA | Kailera Therapeutics, Inc. | 2.57B | 3.50% | 161,977 | - |
| 219 | IDYA | IDEAYA Biosciences, Inc. | 2.56B | 5.47% | 627,383 | 225.27M |
| 220 | CLOV | Clover Health Investments, Corp. | 2.55B | -0.82% | 11,304,352 | 2.21B |
| 221 | ELVN | Enliven Therapeutics, Inc. | 2.47B | 9.81% | 3,638,920 | - |
| 222 | ESTA | Establishment Labs Holdings Inc. | 2.44B | 4.19% | 207,547 | 229.58M |
| 223 | VERA | Vera Therapeutics, Inc. | 2.40B | 5.60% | 338,345 | - |
| 224 | CLDX | Celldex Therapeutics, Inc. | 2.36B | 2.61% | 387,332 | 865.00K |
| 225 | ACHC | Acadia Healthcare Company, Inc. | 2.30B | 4.48% | 566,136 | 3.37B |
| 226 | RARE | Ultragenyx Pharmaceutical Inc. | 2.28B | 0.96% | 410,911 | 670.00M |
| 227 | PBH | Prestige Consumer Healthcare Inc. | 2.26B | -3.01% | 153,776 | 1.09B |
| 228 | AXGN | Axogen, Inc. | 2.25B | 2.25% | 849,078 | 238.11M |
| 229 | PHVS | Pharvaris N.V. | 2.22B | 1.17% | 286,037 | - |
| 230 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.16B | 3.85% | 1,534,063 | 885.72M |
| 231 | LMAT | LeMaitre Vascular, Inc. | 2.09B | -1.12% | 363,150 | 256.28M |
| 232 | IMNM | Immunome, Inc. | 2.08B | 1.32% | 737,566 | 4.02M |
| 233 | SEM | Select Medical Holdings Corporation | 2.06B | 0.15% | 1,025,086 | 5.52B |
| 234 | KOD | Kodiak Sciences Inc. | 2.06B | 5.06% | 232,832 | - |
| 235 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | 1.85% | 391,345 | 298.30M |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.04B | -0.76% | 293,836 | 899.11M |
| 237 | NKTR | Nektar Therapeutics | 2.02B | 5.48% | 355,769 | 55.63M |
| 238 | PGNY | Progyny, Inc. | 2.01B | -0.77% | 522,443 | 1.29B |
| 239 | XRAY | DENTSPLY SIRONA Inc. | 2.00B | -0.80% | 1,886,497 | 3.68B |
| 240 | NEOG | Neogen Corporation | 1.98B | -0.98% | 464,027 | 870.56M |
| 241 | VCEL | Vericel Corporation | 1.97B | 3.40% | 181,399 | 292.09M |
| 242 | ASTH | Astrana Health, Inc. | 1.96B | 2.01% | 228,360 | 3.53B |
| 243 | ADMA | ADMA Biologics, Inc. | 1.96B | -0.35% | 1,667,805 | 509.86M |
| 244 | NVCR | NovoCure Limited | 1.95B | 1.32% | 290,804 | 674.41M |
| 245 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | -0.55% | 585,853 | - |
| 246 | TRVI | Trevi Therapeutics, Inc. | 1.95B | 2.31% | 188,224 | - |
| 247 | ZLAB | Zai Lab Limited | 1.94B | 0.20% | 392,228 | 453.28M |
| 248 | BHC | Bausch Health Companies Inc. | 1.94B | 0.97% | 625,619 | 10.53B |
| 249 | HCM | HUTCHMED (China) Limited | 1.93B | -1.47% | 16,583 | 548.51M |
| 250 | MD | Pediatrix Medical Group, Inc. | 1.93B | 2.04% | 198,260 | 1.93B |
| 251 | OCUL | Ocular Therapeutix, Inc. | 1.92B | 0.23% | 1,048,899 | 52.04M |
| 252 | SGRY | Surgery Partners, Inc. | 1.91B | 3.80% | 682,703 | 3.34B |
| 253 | LKFT | Lakefront Biotherapeutics NV | 1.87B | 0.21% | 90,485 | 1.20B |
| 254 | PLSE | Pulse Biosciences, Inc. | 1.85B | 7.08% | 166,893 | 751.00K |
| 255 | STOK | Stoke Therapeutics, Inc. | 1.83B | 3.20% | 159,118 | 32.08M |
| 256 | UFPT | UFP Technologies, Inc. | 1.83B | 1.65% | 168,614 | 608.85M |
| 257 | AGL | agilon health, inc. | 1.81B | 6.83% | 65,830 | 5.82B |
| 258 | MESO | Mesoblast Limited | 1.79B | -0.07% | 58,042 | 65.38M |
| 259 | VRDN | Viridian Therapeutics, Inc. | 1.77B | 1.52% | 558,633 | 70.92M |
| 260 | WGS | GeneDx Holdings Corp. | 1.75B | 8.34% | 941,951 | 442.68M |
| 261 | IOVA | Iovance Biotherapeutics, Inc. | 1.74B | 3.17% | 6,620,531 | 285.61M |
| 262 | ANIP | ANI Pharmaceuticals, Inc. | 1.73B | -0.34% | 41,152 | 923.71M |
| 263 | AGIO | Agios Pharmaceuticals, Inc. | 1.73B | 0.55% | 1,257,247 | 66.05M |
| 264 | BHVN | Biohaven Ltd. | 1.72B | 3.34% | 1,978,282 | - |
| 265 | RAPP | Rapport Therapeutics, Inc. | 1.72B | 1.87% | 501,917 | 20.00M |
| 266 | NTLA | Intellia Therapeutics, Inc. | 1.71B | 0.57% | 3,638,902 | 66.09M |
| 267 | QURE | uniQure N.V. | 1.71B | 1.29% | 450,296 | 18.09M |
| 268 | NRIX | Nurix Therapeutics, Inc. | 1.71B | 7.97% | 2,062,466 | 71.78M |
| 269 | NBTX | Nanobiotix S.A. | 1.69B | 1.19% | 33,096 | 38.27M |
| 270 | ZYME | Zymeworks Inc. | 1.69B | 1.36% | 264,893 | 81.26M |
| 271 | ADUS | Addus HomeCare Corporation | 1.69B | -0.83% | 59,633 | 1.45B |
| 272 | OMCL | Omnicell, Inc. | 1.69B | -2.78% | 445,871 | 1.23B |
| 273 | INVA | Innoviva, Inc. | 1.67B | -1.48% | 235,337 | 420.69M |
| 274 | SNDA | Sonida Senior Living, Inc. | 1.67B | -0.20% | 216,804 | 367.34M |
| 275 | GENB | Generate Biomedicines, Inc. | 1.67B | -1.29% | 240,184 | 30.30M |
| 276 | NUVB | Nuvation Bio Inc. | 1.65B | 3.71% | 1,726,669 | 143.05M |
| 277 | TSHA | Taysha Gene Therapies, Inc. | 1.63B | 5.00% | 585,134 | 7.47M |
| 278 | RXRX | Recursion Pharmaceuticals, Inc. | 1.62B | 0.66% | 14,829,021 | 66.41M |
| 279 | SION | Sionna Therapeutics, Inc. | 1.62B | 5.67% | 97,342 | - |
| 280 | MBX | MBX Biosciences, Inc. | 1.61B | 9.16% | 1,011,693 | - |
| 281 | PGEN | Precigen, Inc. | 1.60B | 15.42% | 5,135,241 | 31.60M |
| 282 | SNDX | Syndax Pharmaceuticals, Inc. | 1.60B | 2.50% | 552,992 | 217.17M |
| 283 | SRPT | Sarepta Therapeutics, Inc. | 1.59B | -0.36% | 1,379,462 | 2.18B |
| 284 | AAPG | Ascentage Pharma Group International | 1.58B | - | 578 | 82.08M |
| 285 | ABCL | AbCellera Biologics Inc. | 1.57B | 1.28% | 1,956,903 | 79.21M |
| 286 | FTRE | Fortrea Holdings Inc. | 1.57B | 1.59% | 450,669 | 2.71B |
| 287 | PRCT | PROCEPT BioRobotics Corporation | 1.57B | -5.29% | 1,405,925 | 322.02M |
| 288 | ANAB | AnaptysBio, Inc. | 1.57B | 3.32% | 215,681 | 232.39M |
| 289 | AVAH | Aveanna Healthcare Holdings Inc. | 1.54B | 2.76% | 606,001 | 2.52B |
| 290 | TYRA | Tyra Biosciences, Inc. | 1.54B | 1.67% | 646,924 | - |
| 291 | CMPS | COMPASS Pathways plc | 1.52B | 1.81% | 2,186,201 | - |
| 292 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.51B | 0.67% | 944,175 | -665.00K |
| 293 | ALMR | Alamar Biosciences, Inc. | 1.50B | 0.51% | 63,167 | 87.16M |
| 294 | PVLA | Palvella Therapeutics, Inc. | 1.49B | 1.65% | 74,716 | - |
| 295 | PRGO | Perrigo Company plc | 1.47B | -4.88% | 1,115,258 | 4.18B |
| 296 | NEO | NeoGenomics, Inc. | 1.47B | - | 742,401 | 745.97M |
| 297 | HCSG | Healthcare Services Group, Inc. | 1.47B | 0.28% | 294,718 | 1.85B |
| 298 | STAA | STAAR Surgical Company | 1.46B | 0.27% | 120,774 | 290.38M |
| 299 | BFLY | Butterfly Network, Inc. | 1.45B | 2.97% | 2,902,212 | 102.92M |
| 300 | NVAX | Novavax, Inc. | 1.45B | 3.04% | 1,453,766 | 596.34M |
| 301 | SEPN | Septerna, Inc. | 1.45B | 5.42% | 180,197 | 72.26M |
| 302 | GLUE | Monte Rosa Therapeutics, Inc. | 1.45B | 3.57% | 691,480 | 42.95M |
| 303 | IMCR | Immunocore Holdings plc | 1.44B | 1.76% | 93,312 | 412.81M |
| 304 | CAPR | Capricor Therapeutics, Inc. | 1.44B | -1.58% | 563,055 | 11.13M |
| 305 | VIR | Vir Biotechnology, Inc. | 1.44B | 3.76% | 610,241 | 65.50M |
| 306 | ARDX | Ardelyx, Inc. | 1.44B | 4.10% | 1,737,890 | 427.68M |
| 307 | KALV | KalVista Pharmaceuticals, Inc. | 1.44B | - | - | 114.48M |
| 308 | SLS | SELLAS Life Sciences Group, Inc. | 1.43B | 7.69% | 3,407,715 | - |
| 309 | ATRC | AtriCure, Inc. | 1.42B | 1.64% | 405,522 | 552.16M |
| 310 | AVBP | ArriVent BioPharma, Inc. | 1.41B | -0.49% | 185,098 | - |
| 311 | URGN | UroGen Pharma Ltd. | 1.41B | 3.57% | 186,555 | 140.49M |
| 312 | GHRS | GH Research PLC | 1.40B | -0.05% | 124,232 | - |
| 313 | ATAI | AtaiBeckley Inc. | 1.39B | 0.13% | 2,713,980 | 3.49M |
| 314 | HROW | Harrow, Inc. | 1.39B | 3.83% | 317,025 | 268.68M |
| 315 | BCAX | Bicara Therapeutics Inc. | 1.38B | 4.11% | 244,829 | - |
| 316 | ARDT | Ardent Health, Inc. | 1.37B | 2.79% | 196,570 | 6.43B |
| 317 | ALVO | Alvotech | 1.35B | 4.35% | 405,524 | 562.04M |
| 318 | AHCO | AdaptHealth Corp. | 1.34B | 1.51% | 318,272 | 3.29B |
| 319 | IART | Integra LifeSciences Holdings Corporation | 1.34B | 0.64% | 198,940 | 1.64B |
| 320 | SVRA | Savara Inc. | 1.33B | 3.34% | 727,065 | - |
| 321 | MAZE | Maze Therapeutics, Inc. | 1.33B | 1.71% | 333,020 | 20.00M |
| 322 | INBX | Inhibrx Biosciences, Inc. | 1.33B | 1.29% | 176,288 | 1.30M |
| 323 | MPLT | MapLight Therapeutics, Inc. | 1.32B | 5.00% | 77,666 | - |
| 324 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.32B | 0.59% | 1,002,017 | 204.73M |
| 325 | BLFS | BioLife Solutions, Inc. | 1.31B | 0.60% | 248,795 | 101.66M |
| 326 | MLTX | MoonLake Immunotherapeutics | 1.31B | 1.77% | 307,724 | - |
| 327 | TDOC | Teladoc Health, Inc. | 1.31B | 2.84% | 1,699,180 | 2.51B |
| 328 | DMRA | Damora Therapeutics, Inc. | 1.28B | 2.88% | 161,905 | - |
| 329 | PAHC | Phibro Animal Health Corporation | 1.27B | 0.80% | 88,420 | 1.50B |
| 330 | ATEC | Alphatec Holdings, Inc. | 1.27B | 1.23% | 896,929 | 787.08M |
| 331 | IMTX | Immatics N.V. | 1.23B | 1.58% | 92,093 | 43.00M |
| 332 | INNV | InnovAge Holding Corp. | 1.22B | 7.87% | 140,731 | 949.17M |
| 333 | IRMD | IRADIMED CORPORATION | 1.22B | -0.99% | 54,969 | 86.28M |
| 334 | INSP | Inspire Medical Systems, Inc. | 1.21B | -0.50% | 354,456 | 915.25M |
| 335 | CDNA | CareDx, Inc. | 1.21B | - | 235,828 | 412.82M |
| 336 | ENOV | Enovis Corporation | 1.20B | -4.82% | 652,143 | 2.28B |
| 337 | XERS | Xeris Biopharma Holdings, Inc. | 1.20B | 3.87% | 1,153,057 | 314.85M |
| 338 | COAG | Hemab Therapeutics Holdings, Inc. | 1.19B | 5.73% | 82,876 | - |
| 339 | AMN | AMN Healthcare Services, Inc. | 1.19B | 4.73% | 334,164 | 3.42B |
| 340 | AVLN | Avalyn Pharma Inc. | 1.17B | -1.72% | 93,886 | - |
| 341 | AVNS | Avanos Medical, Inc. | 1.17B | 0.02% | 395,210 | 715.90M |
| 342 | KMTS | Kestra Medical Technologies, Ltd. | 1.16B | 2.31% | 40,255 | 83.72M |
| 343 | COLL | Collegium Pharmaceutical, Inc. | 1.14B | 1.29% | 108,087 | 796.33M |
| 344 | MNKD | MannKind Corporation | 1.14B | 1.38% | 1,732,663 | 360.78M |
| 345 | PNTG | The Pennant Group, Inc. | 1.14B | 1.15% | 25,642 | 1.02B |
| 346 | AHG | Akso Health Group | 1.13B | -5.04% | 1,474 | 14.84M |
| 347 | ZBIO | Zenas BioPharma, Inc. | 1.13B | -0.28% | 241,135 | 10.00M |
| 348 | WVE | Wave Life Sciences Ltd. | 1.11B | 2.39% | 1,745,692 | 71.80M |
| 349 | TNDM | Tandem Diabetes Care, Inc. | 1.08B | -2.53% | 1,439,516 | 1.03B |
| 350 | OPK | OPKO Health, Inc. | 1.08B | -0.69% | 1,193,809 | 581.12M |
| 351 | SDGR | Schrödinger, Inc. | 1.06B | 0.14% | 382,330 | 254.91M |
| 352 | CNMD | CONMED Corporation | 1.04B | -4.79% | 185,208 | 1.37B |
| 353 | AKTS | Aktis Oncology, Inc. | 1.04B | 1.29% | 47,370 | 8.28M |
| 354 | OMDA | Omada Health, Inc. | 1.04B | 2.28% | 467,214 | 283.30M |
| 355 | EYPT | EyePoint, Inc. | 1.04B | 0.24% | 712,259 | 7.61M |
| 356 | CRON | Cronos Group Inc. | 1.03B | 0.36% | 521,164 | 159.54M |
| 357 | AZTA | Azenta, Inc. | 1.03B | -0.36% | 374,600 | 596.48M |
| 358 | ABSI | Absci Corporation | 1.02B | 2.19% | 1,817,058 | 1.84M |
| 359 | AORT | Artivion, Inc. | 1.01B | 1.71% | 332,308 | 458.69M |
| 360 | USPH | U.S. Physical Therapy, Inc. | 983.59M | 2.86% | 64,671 | 787.69M |
| 361 | PSNL | Personalis, Inc. | 982.28M | -2.39% | 1,594,993 | 64.52M |
| 362 | NUTX | Nutex Health Inc. | 967.45M | 5.22% | 79,774 | 879.95M |
| 363 | CRVS | Corvus Pharmaceuticals, Inc. | 953.59M | 1.61% | 427,356 | - |
| 364 | SPRY | ARS Pharmaceuticals, Inc. | 950.33M | 3.35% | 350,207 | 98.99M |
| 365 | EVO | Evotec SE | 943.07M | 1.92% | 15,103 | 859.03M |
| 366 | DBVT | DBV Technologies S.A. | 942.28M | 2.96% | 43,468 | 5.74M |
| 367 | SPTX | Seaport Therapeutics, Inc. | 936.21M | 3.13% | 66,205 | - |
| 368 | PCRX | Pacira BioSciences, Inc. | 928.22M | 0.73% | 97,973 | 734.86M |
| 369 | JBIO | Jade Biosciences, Inc. | 925.42M | 2.16% | 294,629 | - |
| 370 | AVR | Anteris Technologies Global Corp. | 922.71M | -1.68% | 444,125 | 1.85M |
| 371 | LMRI | Lumexa Imaging Holdings, Inc. | 919.49M | 5.86% | 277,129 | 1.03B |
| 372 | QDEL | QuidelOrtho Corporation | 902.17M | -2.00% | 756,230 | 2.66B |
| 373 | AMPH | Amphastar Pharmaceuticals, Inc. | 901.04M | 0.71% | 198,527 | 720.53M |
| 374 | MGTX | MeiraGTx Holdings plc | 899.24M | 6.24% | 342,930 | 79.76M |
| 375 | XNCR | Xencor, Inc. | 898.60M | 2.45% | 156,630 | 97.36M |
| 376 | ETON | Eton Pharmaceuticals, Inc. | 886.42M | 4.56% | 111,097 | 86.93M |
| 377 | PHAR | Pharming Group N.V. | 882.51M | 1.79% | 1,842 | 369.49M |
| 378 | DRTS | Alpha Tau Medical Ltd. | 877.41M | 5.30% | 415,979 | - |
| 379 | TALK | Talkspace, Inc. | 873.58M | 0.10% | 1,420,036 | 238.37M |
| 380 | GDRX | GoodRx Holdings, Inc. | 858.54M | -0.98% | 532,001 | 787.89M |
| 381 | INMD | InMode Ltd. | 855.98M | 0.30% | 246,632 | 374.64M |
| 382 | LXRX | Lexicon Pharmaceuticals, Inc. | 850.64M | 1.86% | 913,460 | 69.64M |
| 383 | TBPH | Theravance Biopharma, Inc. | 847.53M | 0.43% | 88,799 | 109.78M |
| 384 | ABUS | Arbutus Biopharma Corporation | 843.49M | 3.64% | 1,140,812 | 191.45M |
| 385 | OLMA | Olema Pharmaceuticals, Inc. | 836.79M | -2.44% | 928,815 | - |
| 386 | JANX | Janux Therapeutics, Inc. | 836.71M | 4.33% | 433,132 | 13.73M |
| 387 | LBRX | LB Pharmaceuticals Inc | 823.31M | 1.13% | 50,209 | - |
| 388 | PHAT | Phathom Pharmaceuticals, Inc. | 818.92M | 4.99% | 343,028 | 204.89M |
| 389 | ESPR | Esperion Therapeutics, Inc. | 809.62M | 0.16% | 7,047,931 | 418.24M |
| 390 | ODTX | Odyssey Therapeutics, Inc. | 807.15M | 5.62% | 72,575 | 2.98M |
| 391 | ORIC | ORIC Pharmaceuticals, Inc. | 799.16M | 2.39% | 849,218 | - |
| 392 | CERT | Certara, Inc. | 794.16M | -1.45% | 1,308,826 | 419.75M |
| 393 | CGEM | Cullinan Therapeutics, Inc. | 792.19M | 6.97% | 624,071 | - |
| 394 | SANA | Sana Biotechnology, Inc. | 790.35M | 0.71% | 1,469,090 | - |
| 395 | ANNX | Annexon, Inc. | 783.17M | 1.27% | 645,811 | - |
| 396 | KURA | Kura Oncology, Inc. | 782.10M | 1.50% | 1,263,527 | 71.64M |
| 397 | IVA | Inventiva S.A. | 779.95M | 1.19% | 438,352 | 7.94M |
| 398 | ZVRA | Zevra Therapeutics, Inc. | 778.55M | -2.44% | 1,410,641 | 122.29M |
| 399 | HSTM | HealthStream, Inc. | 765.73M | -0.42% | 85,300 | 311.78M |
| 400 | GERN | Geron Corporation | 760.20M | 7.73% | 14,732,834 | 196.12M |
| 401 | VOR | Vor Biopharma Inc. | 759.69M | 7.85% | 590,834 | - |
| 402 | EVMN | Evommune, Inc. | 747.02M | 1.22% | 397,869 | 10.00M |
| 403 | OMER | Omeros Corporation | 743.29M | 0.69% | 459,208 | 9.89M |
| 404 | BVS | Bioventus Inc. | 735.94M | -2.65% | 265,392 | 576.30M |
| 405 | REPL | Replimune Group, Inc. | 731.59M | 4.60% | 988,515 | - |
| 406 | ANRO | Alto Neuroscience, Inc. | 727.85M | 5.39% | 133,422 | - |
| 407 | SSII | SS Innovations International, Inc. | 710.47M | 0.85% | 36,349 | 48.47M |
| 408 | GMRS | GMR Solutions Inc. | 709.71M | -0.30% | 191,464 | 5.83B |
| 409 | SLDB | Solid Biosciences Inc. | 706.87M | 8.62% | 764,096 | - |
| 410 | CRMD | CorMedix Inc. | 706.85M | 2.74% | 469,753 | 400.05M |
| 411 | AURA | Aura Biosciences, Inc. | 704.81M | 4.41% | 444,052 | - |
| 412 | AVTX | Avalo Therapeutics, Inc. | 704.38M | 2.29% | 369,115 | 59.00K |
| 413 | BIOA | BioAge Labs, Inc. | 701.91M | 2.00% | 369,971 | 10.32M |
| 414 | NNNN | Anbio Biotechnology | 692.16M | -4.02% | 38,417 | 8.65M |
| 415 | RLMD | Relmada Therapeutics, Inc. | 683.88M | 2.19% | 450,638 | - |
| 416 | CBLL | CeriBell, Inc. | 682.21M | -2.18% | 66,615 | 95.07M |
| 417 | SIBN | SI-BONE, Inc. | 681.65M | - | 107,958 | 206.22M |
| 418 | OCS | Oculis Holding AG | 667.29M | 0.73% | 211,308 | 1.40M |
| 419 | DSGN | Design Therapeutics, Inc. | 659.55M | -0.94% | 312,183 | - |
| 420 | CTMX | CytomX Therapeutics, Inc. | 650.93M | 2.75% | 1,246,839 | 35.54M |
| 421 | BBNX | Beta Bionics, Inc. | 641.24M | 4.88% | 568,165 | 110.24M |
| 422 | ALLO | Allogene Therapeutics, Inc. | 638.54M | 3.93% | 3,561,621 | 22.00K |
| 423 | CSTL | Castle Biosciences, Inc. | 634.81M | -0.71% | 66,807 | 339.92M |
| 424 | TENX | Tenax Therapeutics, Inc. | 632.35M | 1.80% | 516,822 | - |
| 425 | CBIO | Crescent Biopharma, Inc. | 617.06M | 5.69% | 57,837 | 11.88M |
| 426 | DRUG | Bright Minds Biosciences Inc. | 614.69M | -0.50% | 328,143 | - |
| 427 | SGP | SpyGlass Pharma, Inc. | 607.53M | 1.14% | 33,984 | - |
| 428 | CADL | Candel Therapeutics, Inc. | 606.68M | -0.84% | 848,486 | - |
| 429 | IRWD | Ironwood Pharmaceuticals, Inc. | 601.66M | 9.10% | 1,063,530 | 361.51M |
| 430 | ACRS | Aclaris Therapeutics, Inc. | 600.55M | 4.88% | 383,503 | 8.37M |
| 431 | TLRY | Tilray Brands, Inc. | 598.80M | - | 1,380,853 | 858.28M |
| 432 | TRAX | First Tracks Biotherapeutics, Inc. | 595.26M | 3.90% | 282,925 | - |
| 433 | ACHV | Achieve Life Sciences, Inc. | 593.37M | 0.52% | 1,894,571 | - |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 590.79M | 3.58% | 104,758 | - |
| 435 | RIGL | Rigel Pharmaceuticals, Inc. | 589.85M | 3.14% | 127,136 | 299.77M |
| 436 | TCMD | Tactile Systems Technology, Inc. | 586.01M | 0.04% | 49,422 | 343.52M |
| 437 | IMMX | Immix Biopharma, Inc. | 568.44M | -0.43% | 524,071 | - |
| 438 | BWAY | BrainsWay Ltd. | 568.40M | 2.12% | 21,910 | 56.22M |
| 439 | GYRE | Gyre Therapeutics, Inc. | 558.28M | 2.69% | 39,882 | 117.05M |
| 440 | PHR | Phreesia, Inc. | 556.31M | -1.53% | 369,796 | 495.59M |
| 441 | TECX | Tectonic Therapeutic, Inc. | 545.04M | 2.98% | 43,480 | - |
| 442 | NPCE | NeuroPace, Inc. | 539.70M | 0.76% | 37,030 | 99.53M |
| 443 | MDXG | MiMedx Group, Inc. | 539.18M | -0.55% | 461,341 | 389.42M |
| 444 | FLGT | Fulgent Genetics, Inc. | 537.91M | 0.05% | 79,249 | 320.35M |
| 445 | CTEV | Claritev Corporation | 532.40M | 5.01% | 38,039 | 978.76M |
| 446 | CLYM | Climb Bio, Inc. | 526.41M | 2.04% | 607,273 | - |
| 447 | AQST | Aquestive Therapeutics, Inc. | 524.38M | 4.76% | 813,751 | 50.27M |
| 448 | XOMA | XOMA Royalty Corporation | 523.96M | 0.05% | 66,520 | 48.56M |
| 449 | EVH | Evolent Health, Inc. | 512.91M | 2.01% | 708,708 | 1.89B |
| 450 | CTKB | Cytek Biosciences, Inc. | 510.76M | -2.35% | 1,119,714 | 204.17M |
| 451 | ALT | Altimmune, Inc. | 509.52M | 0.38% | 1,924,386 | 36.00K |
| 452 | PRME | Prime Medicine, Inc. | 509.34M | 4.06% | 1,484,734 | 4.03M |
| 453 | CERS | Cerus Corporation | 508.94M | -0.78% | 1,437,929 | 216.56M |
| 454 | DNA | Ginkgo Bioworks Holdings, Inc. | 507.57M | -2.14% | 524,329 | 151.40M |
| 455 | TOI | The Oncology Institute, Inc. | 506.91M | 8.33% | 924,740 | 545.76M |
| 456 | ANGO | AngioDynamics, Inc. | 505.19M | -1.30% | 57,674 | 313.73M |
| 457 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 458 | PROK | ProKidney Corp. | 501.42M | -0.60% | 283,103 | 889.00K |
| 459 | AGMB | AgomAb Therapeutics NV | 498.39M | -2.03% | 99,499 | - |
| 460 | CABA | Cabaletta Bio, Inc. | 497.32M | 0.33% | 1,375,916 | - |
| 461 | VALN | Valneva SE | 492.14M | -1.52% | 8,067 | 180.25M |
| 462 | KYTX | Kyverna Therapeutics, Inc. | 475.16M | 2.48% | 286,513 | - |
| 463 | SRTA | Strata Critical Medical, Inc. | 474.17M | - | 496,945 | 228.58M |
| 464 | KIDS | OrthoPediatrics Corp. | 462.84M | -2.38% | 17,591 | 243.30M |
| 465 | ARVN | Arvinas, Inc. | 460.04M | 2.15% | 272,171 | 89.40M |
| 466 | EIKN | Eikon Therapeutics, Inc. | 458.01M | 1.20% | 116,412 | - |
| 467 | VREX | Varex Imaging Corporation | 456.87M | 2.94% | 111,381 | 857.50M |
| 468 | NGNE | Neurogene Inc. | 455.25M | 2.86% | 60,791 | 925.00K |
| 469 | STRO | Sutro Biopharma, Inc. | 450.22M | 4.14% | 129,906 | 99.61M |
| 470 | FDMT | 4D Molecular Therapeutics, Inc. | 446.44M | -2.06% | 305,349 | 88.24M |
| 471 | CTNM | Contineum Therapeutics, Inc. | 437.79M | 3.63% | 64,035 | - |
| 472 | PRTA | Prothena Corporation plc | 437.15M | 5.56% | 369,277 | 57.94M |
| 473 | WEAV | Weave Communications, Inc. | 436.02M | -1.79% | 417,690 | 248.72M |
| 474 | NRC | NRC Health | 434.06M | -9.49% | 108,919 | 138.64M |
| 475 | EOLS | Evolus, Inc. | 433.98M | -1.93% | 233,810 | 301.79M |
| 476 | MYGN | Myriad Genetics, Inc. | 433.52M | 3.61% | 618,399 | 829.00M |
| 477 | ASMB | Assembly Biosciences, Inc. | 433.21M | -1.80% | 119,852 | 71.10M |
| 478 | FBRX | Forte Biosciences, Inc. | 430.56M | 4.76% | 63,660 | - |
| 479 | EBS | Emergent BioSolutions Inc. | 428.77M | 0.85% | 251,650 | 676.80M |
| 480 | CCCC | C4 Therapeutics, Inc. | 426.79M | -0.26% | 1,382,762 | 34.86M |
| 481 | MOBI | Mobia Medical, Inc. | 418.70M | -0.51% | 84,454 | 32.04M |
| 482 | AUTL | Autolus Therapeutics plc | 417.84M | 6.08% | 590,536 | 92.62M |
| 483 | KMDA | Kamada Ltd. | 417.22M | 1.53% | 6,473 | 181.68M |
| 484 | OCGN | Ocugen, Inc. | 416.38M | 3.36% | 3,223,701 | 4.47M |
| 485 | PACB | Pacific Biosciences of California, Inc. | 416.21M | -2.19% | 2,877,815 | 160.03M |
| 486 | CLPT | ClearPoint Neuro, Inc. | 413.26M | 0.22% | 178,360 | 40.61M |
| 487 | OVID | Ovid Therapeutics Inc. | 410.61M | -3.51% | 1,621,342 | 7.12M |
| 488 | CCRN | Cross Country Healthcare, Inc. | 408.53M | -0.04% | 115,330 | 1.00B |
| 489 | IPSC | Century Therapeutics, Inc. | 407.60M | 6.60% | 440,694 | 109.16M |
| 490 | CYH | Community Health Systems, Inc. | 405.01M | 0.67% | 755,641 | 12.29B |
| 491 | RZLT | Rezolute, Inc. | 402.20M | 1.05% | 428,139 | - |
| 492 | ANL | Adlai Nortye Ltd. | 400.40M | -4.39% | 30,868 | 5.00M |
| 493 | DCTH | Delcath Systems, Inc. | 400.11M | 3.57% | 547,539 | 90.44M |
| 494 | VMD | Viemed Healthcare, Inc. | 397.94M | 2.47% | 82,415 | 286.57M |
| 495 | PRLD | Prelude Therapeutics Incorporated | 396.71M | 1.27% | 60,885 | 16.72M |
| 496 | SGMT | Sagimet Biosciences Inc. | 394.29M | -1.77% | 382,553 | - |
| 497 | MNPR | Monopar Therapeutics Inc. | 391.54M | -1.63% | 60,084 | - |
| 498 | CGC | Canopy Growth Corporation | 390.96M | -1.26% | 6,592,312 | 203.04M |
| 499 | SI | Shoulder Innovations, Inc. | 388.22M | 4.64% | 79,217 | 53.89M |
| 500 | EPRX | Eupraxia Pharmaceuticals Inc. | 387.87M | 1.35% | 70,233 | - |